Citation Impact
Citing Papers
Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial
2014 Standout
NOTCH Signaling Is Required for Formation and Self-Renewal of Tumor-Initiating Cells and for Repression of Secretory Cell Differentiation in Colon Cancer
2010 StandoutNobel
Nuclear Lamin-A Scales with Tissue Stiffness and Enhances Matrix-Directed Differentiation
2013 StandoutScience
Differential Roles of Macrophages in Diverse Phases of Skin Repair
2010 Standout
Pharmacologic Targeting of Hypoxia-Inducible Factors
2019 StandoutNobel
A RASSF1A-HIF1α loop drives Warburg effect in cancer and pulmonary hypertension
2019 StandoutNobel
Hypoxia, Hypoxia-inducible Transcription Factors, and Renal Cancer
2015 StandoutNobel
Hallmarks of Cancer: The Next Generation
2011 Standout
HIF Hydroxylase Pathways in Cardiovascular Physiology and Medicine
2015 StandoutNobel
Diabetic retinopathy
2010 Standout
Traditional Chinese Medicine for Cardiovascular Disease
2017 Standout
Clinical translation of angiogenesis inhibitors
2002 Standout
AKT/PKB Signaling: Navigating Downstream
2007 Standout
Vascular endothelial growth factor-A: A multifunctional molecular player in diabetic retinopathy
2009
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
Down-Regulation of Angiopoietin-1 Expression in Menorrhagia
2002
Alternative splicing in angiogenesis: The vascular endothelial growth factor paradigm
2006
Pigment epithelium-derived factor (PEDF) and vascular endothelial growth factor (VEGF) in aged human choroid and eyes with age-related macular degeneration
2005
The Risk–Benefit Profile of Commonly Used Herbal Therapies: Ginkgo, St. John's Wort, Ginseng, Echinacea, Saw Palmetto, and Kava
2002 Standout
Lymphangiogenesis: Molecular Mechanisms and Future Promise
2010 Standout
PLGA-based nanoparticles: An overview of biomedical applications
2012 Standout
Retinopathy of prematurity
2013 Standout
Systems Biology of Vascular Endothelial Growth Factors
2008
VEGF polymorphisms are associated with neovascular age-related macular degeneration
2006
The multilayered complexity of ceRNA crosstalk and competition
2014 StandoutNature
IL-21 and T follicular helper cells
2009
Macrophages in atherosclerosis: a dynamic balance
2013 Standout
Angiogenesis in health and disease
2003 Standout
Mechanisms of resistance to antiangiogenesis therapy
2010
Age-related macular degeneration
2012 Standout
Hypoxia and the extracellular matrix: drivers of tumour metastasis
2014 StandoutNobel
VEGF receptor signalling ? in control of vascular function
2006 Standout
Ephrin-B2 regulates VEGFR2 function in developmental and tumour angiogenesis
2010 Nature
Epithelial–mesenchymal transitions in tumour progression
2002 Standout
Angiogenic imbalance in the pathophysiology of preeclampsia: Newer insights
2004
Role and Therapeutic Potential of VEGF in the Nervous System
2009
Vascular endothelial growth factor in eye disease
2008 Standout
Microvascular Modifications in Diabetic Retinopathy
2011
Development, maintenance and disruption of the blood-brain barrier
2013 Standout
Met receptor tyrosine kinase: enhanced signaling through adapter proteins
2000
Molecular regulation of angiogenesis and lymphangiogenesis
2007 Standout
Recombinant human VEGF165b protein is an effective anti-cancer agent in mice
2008
Alternative splicing and differential gene expression in colon cancer detected by a whole genome exon array
2006
The role of vascular endothelial growth factor and other endogenous interplayers in age-related macular degeneration
2008
Basic and Therapeutic Aspects of Angiogenesis
2011 Standout
Vascular endothelial growth factor and diabetic complications
2008
Vascular endothelial growth factor: a neurovascular target in neurological diseases
2016
Reconciling the distinct roles of angiogenic/anti-angiogenic factors in the placenta and maternal circulation of normal and pathological pregnancies
2019
Soluble Endoglin and Other Circulating Antiangiogenic Factors in Preeclampsia
2006 Standout
Evidence for Pro-angiogenic Functions of VEGF-Ax
2016
Soluble endoglin contributes to the pathogenesis of preeclampsia
2006 Standout
Herbal Medicines and Perioperative Care
2001 Standout
Molecular mechanisms and clinical applications of angiogenesis
2011 StandoutNature
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
Programmed Translational Readthrough Generates Antiangiogenic VEGF-Ax
2014
Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner
2012 StandoutNobel
Alternative transcription and alternative splicing in cancer
2012
Mediators involved in retinopathy of prematurity and emerging therapeutic targets
2011
The beneficial effects of the herbal medicine Di-huang-yin-zi (DHYZ) on patients with ischemic stroke: A Randomized, Placebo controlled clinical study
2015
Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders
2011 Standout
Tumorigenesis and the angiogenic switch
2003 Standout
Chronic Intermittent Hypoxia Induces Atherosclerosis via Activation of Adipose Angiopoietin-like 4
2013 StandoutNobel
Ionizable Lipid Nanoparticles for In Vivo mRNA Delivery to the Placenta during Pregnancy
2023 StandoutNobel
Angiopoietin-like 4 is a potent angiogenic factor and a novel therapeutic target for patients with proliferative diabetic retinopathy
2015 StandoutNobel
Orthogonal Design of Experiments for Engineering of Lipid Nanoparticles for mRNA Delivery to the Placenta
2023 StandoutNobel
Hypoxia‐inducible protein 2 is a novel lipid droplet protein and a specific target gene of hypoxia‐inducible factor‐1
2010
VEGF-A and the Induction of Pathological Angiogenesis
2007
Echinacea for preventing and treating the common cold
2014
Vascular Endothelial Growth Factor: Basic Science and Clinical Progress
2004 Standout
Angiomotin
2001
Hypoxia Is Present in Murine Atherosclerotic Plaques and Has Multiple Adverse Effects on Macrophage Lipid Metabolism
2011
VEGF Secreted by Hypoxic Müller Cells Induces MMP-2 Expression and Activity in Endothelial Cells to Promote Retinal Neovascularization in Proliferative Diabetic Retinopathy
2013 StandoutNobel
Oxygen Sensing, Hypoxia-Inducible Factors, and Disease Pathophysiology
2013 StandoutNobel
The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions
2005 Standout
Biophysical properties of normal and diseased renal glomeruli
2010
Inositol Polyphosphate Multikinase Inhibits Angiogenesis via Inositol Pentakisphosphate-Induced HIF-1α Degradation
2017 StandoutNobel
Endothelial/Pericyte Interactions
2005 Standout
Rat aorta-derived mural precursor cells express the Tie2 receptor and respond directly to stimulation by angiopoietins
2003
Angiogenic imbalance in the pathophysiology of preeclampsia: Newer insights
2004
Hypoxic retinal Müller cells promote vascular permeability by HIF-1–dependent up-regulation of angiopoietin-like 4
2013 StandoutNobel
Regulation of cell proliferation by hypoxia-inducible factors
2015 StandoutNobel
Angiogenesis in Endocrine Tumors
2003
Intraperitoneal VEGF Inhibition Using Bevacizumab: A Potential Approach for the Symptomatic Treatment of Malignant Ascites?
2009
Works of Yan Qiu being referenced
RNA interference for HIF-1α inhibits foam cells formation in vitro
2007
Angiopoietin-1 and Angiopoietin-2 Activate Trophoblast Tie-2 to Promote Growth and Migration during Placental Development
2000
Overexpression of VEGF165b in Podocytes Reduces Glomerular Permeability
2010
Chromosomal localization of rat hepatocyte growth factor (Hgf) and HGF receptor (Met) and characterization of HGF receptor cDNA
1997
Protective Effects of Guizhi-Fuling-Capsules on Rat Brain Ischemia/Reperfusion Injury
2007
Diabetic retinopathy is associated with a switch in splicing from anti- to pro-angiogenic isoforms of vascular endothelial growth factor
2005
Detection of VEGF-Axxxb Isoforms in Human Tissues
2013
VEGF-A165b Is an Endogenous Neuroprotective Splice Isoform of Vascular Endothelial Growth Factor A in Vivo and in Vitro
2013
VEGF165b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy
2008
Expression of VEGFxxxb, the inhibitory isoforms of VEGF, in malignant melanoma
2007
Recombinant Human VEGF165b Inhibits Experimental Choroidal Neovascularization
2010
VEGF165b, an Inhibitory Vascular Endothelial Growth Factor Splice Variant
2004
Mammary alveolar development during lactation is inhibited by the endogenous antiangiogenic growth factor isoform, VEGF 165 b
2007
The endogenous anti-angiogenic family of splice variants of VEGF, VEGFxxxb, are down-regulated in pre-eclamptic placentae at term
2006
Chinese medicinal herbs for the common cold
2007